Stock Events

Zylox-Tonbridge Medical Technology. 

HK$11.1
0
+HK$0.08+0.73% Thursday 08:08

Statistik

Tag Hoch
11.1
Tag Tief
10.96
52W Hoch
14.66
52W Niedrig
7.2
Volumen
230,085
Durch. Volumen
530,629
Marktkap.
4.17B
KGV
-
Dividendenrendite
-
Dividende
-

Demnächst

Gewinne

19AugErwartet
Q2 2023
Q4 2023
Q1 2024
Q2 2024
0.23
0.56
0.89
1.23
Erwartetes EPS
K.A.
Tatsächliches EPS
0.22770169240000002

Leute folgen auch

Diese Liste basiert auf den Watchlists von Personen auf Stock Events, die 2190.HK folgen. Es handelt sich nicht um eine Anlageempfehlung.

Wettbewerber

Diese Liste ist eine Analyse basierend auf aktuellen Marktereignissen. Es ist keine Anlageempfehlung.

Über

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices the People's Republic of China and internationally. The company develops neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, stenosis, carotid artery, and vascular access device. It also develops peripheral-vascular interventional product portfolio covering a spectrum of arterial and venous products comprising stents, balloons, catheters, and filters, as well as covers hemodialysis access, aortic intervention, peripheral embolization intervention, and radiological intervention products. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.
Show more...
CEO
Dr. Zhong Zhao
Mitarbeiter
594
Land
Hong Kong
ISIN
CNE100004JD2

Börsen